BIOGAIA AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 116.5 SEK | +1.13% |
|
-0.09% | +15.12% |
| 04-03 | Nordic Shares Rose Wednesday; BW LPG Led Increases | DJ |
| 03-28 | Nordic Shares Decreased Thursday; BioGaia Series B Posted Biggest Loss | DJ |
Chart calendar BioGaia AB
565e7261bb8adabbfb64d6.FXgWaJ5hfAnXdjhnyVtu3RJP2GWXFnb5CeMgpKbdxkg.Sg9sGOsMI0uyO0E9gGsIv1U_hwyiSQSOR7VW4uO38X9KIVAE-wtMRYgcDA~401eea6deb755e0f03cfe108c416ba4c
Upcoming events on BioGaia AB
Past events on BioGaia AB
| 07/02/2024 08:30 | Q4 2023 Earnings Call |
| 07/02/2024 07:00 | Q4 2023 Earnings Release |
| 20/10/2023 08:30 | Q3 2023 Sales and Revenue Call - Interim Management Statement |
| 20/10/2023 07:00 | Q3 2023 Sales and Revenue Release - Interim Management Statement |
| 21/07/2023 08:30 | Q2 2023 Earnings Call |
| 21/07/2023 07:00 | Q2 2023 Earnings Release |
| 07/06/2023 | Handelsbanken Nordic Mid Small Cap Seminar |
| 07/05/2023 | Ex-dividend day for final dividend |
| 07/05/2023 | Ex-dividend day for extraordinary dividend |
| 05/05/2023 15:00 | Annual General Meeting |
| 05/05/2023 08:30 | Q1 2023 Sales and Revenue Call - Interim Management Statement |
| 05/05/2023 07:00 | Q1 2023 Sales and Revenue Release - Interim Management Statement |
| 13/03/2023 | Nordic Healthcare Seminar |
| 03/02/2023 08:30 | FY 2022 Earnings Call |
| 03/02/2023 07:00 | FY 2022 Earnings Release |
| 21/10/2022 08:30 | Q3 2022 Sales and Revenue Call - Interim Management Statement |
| 21/10/2022 07:00 | Q3 2022 Sales and Revenue Release - Interim Management Statement |
| 22/07/2022 08:30 | Interim 2022 Earnings Call |
| 22/07/2022 07:00 | Interim 2022 Earnings Release |
| 17/05/2022 | Split: 5 of 1 |
Past dividends on BioGaia AB
| 07/05/2023 | Bonus Payment 1.45 SEK |
| 07/05/2023 | Annual 1.45 SEK |
| 08/05/2022 | Bonus Payment 11.29 SEK |
| 08/05/2022 | Annual 3.63 SEK |
| 06/05/2021 | Annual 3.41 SEK |
| 07/05/2020 | Annual 3.75 SEK |
| 08/05/2019 | Bonus Payment 5.95 SEK |
| 08/05/2019 | Annual 4.05 SEK |
| 25/04/2018 | Bonus Payment 4.69 SEK |
| 25/04/2018 | Annual 4.31 SEK |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 768 769 -0.07% | 747 743 0.49% | 785 760 3.32% | 1 104 1 101 0.31% | 1 297 1 281 1.23% | 1 423 |
|
EBITDA Million SEK | Released Forecast Spread | 258 246 4.75% | 249 257 -3.31% | 281 267 5.37% | 385 382 0.8% | 468 460 1.8% | 518 |
|
EBIT Million SEK | Released Forecast Spread | 243 239 1.55% | 228 242 -5.69% | 254 248 2.46% | 361 357 1.17% | 443 435 1.86% | 491 |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | 242 239 1.55% | 228 241 -5.75% | 253 247 2.26% | 448 363 23.24% | 469 460 2% | 516 |
|
Net income Million SEK | Released Forecast Spread | 187 184 1.84% | 180 186 -3.63% | 196 194 1.28% | 374 287 30.2% | 365 356 2.56% | 403 |
|
EPS SEK | Released Forecast Spread | 2,16 2,12 1.79% | 2,01 2,03 -0.59% | 1,94 1,92 1.36% | 3,70 2,84 30.28% | 3,62 3,53 2.55% | 3,99 |
| Announcement Date | 06/02/20 | 04/02/21 | 04/02/22 | 03/02/23 | 07/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q2 | 2022 Q3 |
|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 206 168 22.74% | 288 221 30.36% | 258 190 35.65% |
|
EBITDA Million SEK | Released Forecast Spread | 58,2 48,0 21.3% | 107 63,0 70.45% | 98,9 40,0 147.14% |
|
EBIT Million SEK | Released Forecast Spread | 53,1 42,0 26.43% | 101 58,0 74.66% | 93,7 35,0 167.81% |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | 52,6 42,0 25.32% | 99,0 58,0 70.68% | 98,8 35,0 182.29% |
|
Net income Million SEK | Released Forecast Spread | 38,3 33,0 16.06% | 78,5 46,0 70.75% | 79,5 27,0 194.46% |
|
EPS SEK | Released Forecast Spread | 0,38 0,35 8.26% | 0,78 0,46 71.05% | 0,79 0,27 190.44% |
| Announcement Date | 04/02/22 | 22/07/22 | 21/10/22 |
| Today 12:00 | INCYTE CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 | BRIDGEBIO PHARMA, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | TWIST BIOSCIENCE CORPORATION: Q2 2024 Earnings Release |
| 01/05/2024 | SK BIOSCIENCE CO.,LTD.: Q1 2024 Earnings Release |
| 06/05/2024 12:00 | AXSOME THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 06/05/2024 | BIOTEST AG: Q1 2024 Earnings Release |
| 06/05/2024 | AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
| 06/05/2024 | REVANCE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 06/05/2024 | APELLIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 07/05/2024 07:00 | BIOGAIA AB: Q1 2024 Earnings Release |
Past sector events for BioGaia AB
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BIOG B Stock
- Calendar BioGaia AB
